VILLEPINTE, France, June 13, 2022 /PRNewswire/ Guerbet (EuronextParis: GBT) (ISIN: FR0000032526), a global leader in medical imaging, announces today that Elucirem, the proposed Guerbet brand
21.04.2022 - Q1 2022 sales Business growth Sales Increase of 2.7% compared with Q1 2021 (€181.1m)Up 0.5% at constant exchange rates (CER1) 2022 guidance confirmed Villepinte, Thursday, April 21, 2022 – Guerbet (FR0000032526 GBT), a global specialist in . Seite 1
/PRNewswire/ Guerbet (FR0000032526 GBT), a global leader in medical imaging offering a comprehensive range of pharmaceutical products, medical devices, and.